Legal Loopholes: How a $32 Million Cannabis Contract Dispute Was Dismissed

Send us Fan Mail

Curaleaf’s $31.8M Contract Verdict Tossed, Schedule III Can’t Be Enjoined, and Regulators Crack Down

The hosts discuss cannabis legalization and business news, arguing that federal marijuana rescheduling to Schedule III is inevitable and noting a court denial of injunctive relief seeking to block it, with briefing planning due by October 9 and an amicus request granted. They cover a roughly $31.8 million marijuana contract verdict tied to an output contract dispute that was moved to federal court and dismissed on federal illegality grounds, warning that federal courts remain effectively closed to marijuana contract enforcement even after rescheduling, including for medical contracts. Additional topics include Washington State banning strain names that mimic children’s candy (e.g., “Runts,” “Skittles,” “Gushers”), Colorado regulators’ handling of a harmful edible product, limited cannabis banking participation per GAO data, dormant Commerce Clause splits, CDC overdose-death cannabis detection context, Nebraska’s medical cannabis laws upheld, and the hosts’ dispensary operations, local medical sales and lounge efforts, and business-building plans.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu